Aardvark Therapeutics, Inc
Fundamentals
Oldest to newest| Line | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Revenue | none on file | none on file | $0.00 |
| Operating income | none on file | −$22.8M | −$62.7M |
| Net income | none on file | −$20.6M | −$57.6M |
| Operating cash flow | none on file | −$18.1M | −$54.2M |
| Free cash flow | none on file | −$18.2M | −$54.3M |
| Cash | $9.7M | $61.6M | $47.1M |
| Shares outstanding | none on file | 4.1M | 21.8M |